Deep Diamond India Ltd

Deep Health AI India Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results along with the draft Limited Review Report. The company also confirmed the closure and subsequent reopening of the trading window for its shares, adhering to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Board meeting to approve these results commenced at 3:00 PM and concluded at 3:40 PM on August 13, 2026.

Deep Health AI India Ltd has announced a Board of Directors meeting scheduled for August 13, 2026. The primary agenda is to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. In anticipation of this meeting, the company has closed its trading window for directors, KMPs, designated employees, and connected persons from July 1, 2026, until 48 hours after the financial results are declared. This measure aligns with SEBI regulations on insider trading.

Deep Health AI India Ltd. announced the appointment of two Non-Executive Independent Directors, Mr. Bhupesh Swami and Mrs. Shashi Kala Dhabriya. The appointments were approved by shareholders at an Extra-Ordinary Meeting held on July 30, 2026. Mr. Swami's appointment is effective from July 2, 2026, for a term of two years, while Mrs. Dhabriya's is effective from March 20, 2026, for five years. Both directors are not related to any other directors of the company. Mr. Swami brings over 20 years of experience in logistics, marketing, and import-export operations, enhancing the board's operational expertise.

Deep Health AI India Ltd has entered into a Memorandum of Understanding (MoU) dated March 06, 2026, with M/s. Elegant Floriculture & Agrotech (India) Limited for the acquisition of land in Pune, Maharashtra. The land, measuring 49,100 sq. mtr., is intended for the development of a naturopathy and holistic rejuvenation centre, including medicinal plant cultivation. The company has already made an aggregate advance payment of ₹2,85,00,000/- towards this acquisition, with the last tranche paid on June 06, 2026. The disclosure of this transaction was delayed due to an oversight but has now been rectified. This move aligns with the company's focus on preventive healthcare and agro-tourism.

Deep Health AI India Ltd has issued a revised Auditor's Report for its Audited Standalone and Consolidated Financial Results for the financial year ended March 31, 2026. The revision was due to an inadvertent omission in the original report where the names of entities covered under the Consolidated Financial Statements were not mentioned. The company clarifies that this omission does not impact the financial results or the audit opinion. The revised report has been submitted to the stock exchange, and the company regrets any inconvenience caused. The audit opinion confirms the financial statements give a true and fair view in accordance with Indian Accounting Standards.

Deep Health AI India Ltd has announced an Extra-Ordinary General Meeting (EGM) to be held on Thursday, July 30, 2026, at 03:00 P.M. (IST) via Video Conferencing. The primary agenda is to seek shareholder approval for the appointment of Mr. Bhupesh Swami (DIN:07999261) as a Non-Executive Independent Director. The company is facilitating e-voting for members from July 27 to July 29, 2026, with NSDL appointed as the e-voting agency. The EGM notice and explanatory statement have been sent via email to registered members.

Deep Health AI India Ltd has announced an Extra-Ordinary General Meeting (EGM) to be held on Thursday, July 30, 2026, at 03:00 P.M. (IST) via Video Conferencing or Other Audio Visual Means. The meeting aims to seek shareholder approval for resolutions outlined in the EGM Notice. In compliance with the Companies Act, 2013, and SEBI Listing Regulations, the company is providing an e-voting facility. The cut-off date for determining eligible members for e-voting is Thursday, July 23, 2026. E-voting will commence on Monday, July 27, 2026, at 9:00 a.m. (IST) and conclude on Tuesday, July 29, 2026, at 5:00 p.m. (IST). National Securities Depository Limited (NSDL) has been engaged for the e-voting process. The EGM Notice has been sent electronically to members who have registered their email addresses.

Deep Health AI India Ltd announced that its Board of Directors, in a meeting held on July 02, 2026, approved the convening of an Extra Ordinary General Meeting (EGM) on July 30, 2026, at 03:00 P.M. at the company's registered office. The draft notice for this EGM was also approved. The Board meeting commenced at 05:30 P.M. and concluded at 08:25 P.M. The company was formerly known as Deep Diamond India Limited.

Deep Health AI India Ltd announced the appointment of Mr. Bhupesh Swami as an Additional Non-Executive Independent Director to its Board of Directors. The decision was made via a Circular Resolution on July 02, 2026. Mr. Swami's appointment is for a term of two years, effective from July 02, 2026, to July 01, 2028. He holds a Master India Boards (MIB) with a specialization in Export-Import from CMS, Udaipur, completed in 2016. The company confirmed that Mr. Swami is not related to any other directors on the board. This appointment is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Deep Health AI India Ltd has announced the closure of its trading window for dealing in equity shares. This closure is effective from the trading hours of July 01, 2026, and will continue until 48 hours after the declaration of the Un-Audited Financial Results for the Quarter ended June 30, 2026. The measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations. All designated persons and their immediate relatives are prohibited from trading in the company's securities during this period. The date for the Board meeting to approve the financial results will be communicated separately.